Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Working Capital Changes (2016 - 2025)

Assembly Biosciences has reported Other Working Capital Changes over the past 11 years, most recently at $28.2 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $28.2 million for Q4 2025, up 258.0% from a year ago — trailing twelve months through Dec 2025 was -$751000.0 (up 94.35% YoY), and the annual figure for FY2025 was $6649.0, down 93.52%.
  • Other Working Capital Changes for Q4 2025 was $28.2 million at Assembly Biosciences, up from -$9.9 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ASMB hit a ceiling of $28.2 million in Q4 2025 and a floor of -$18.9 million in Q2 2025.
  • Median Other Working Capital Changes over the past 5 years was -$158500.0 (2022), compared with a mean of -$750614.4.
  • Biggest five-year swings in Other Working Capital Changes: crashed 28230.43% in 2022 and later soared 378.75% in 2024.
  • Assembly Biosciences' Other Working Capital Changes stood at $5.1 million in 2021, then crashed by 72.42% to $1.4 million in 2022, then tumbled by 298.94% to -$2.8 million in 2023, then soared by 378.75% to $7.9 million in 2024, then skyrocketed by 258.0% to $28.2 million in 2025.
  • The last three reported values for Other Working Capital Changes were $28.2 million (Q4 2025), -$9.9 million (Q3 2025), and -$18.9 million (Q2 2025) per Business Quant data.